Frontage Laboratories, Inc. (Frontage laboratories, Inc.) is located in Malvern, Pennsylvania, and Shanghai, China. It is a fast-growing service company supporting drug research and development. The company was established at the beginning of 2006. The service items: pre-clinical research, bioanalysis, drug development (CMC), drug registration and consulting.

Fonda’s Malvern laboratory is a laboratory established in accordance with the FDA’s GMP and GLP requirements. It provides international pharmaceutical companies with FDA-compliant scientific research services. The laboratory has passed FDA inspections and won praise. It is the first in China GLP laboratory established and operated in accordance with US FDA standards. On January 8, 2019, Fangda Pharmaceutical signed a contract with CEIDI Xidi.

Project Overview

Project name: Construction of the first and second laboratory buildings of Fangda Pharmaceutical

Project location: No. 1227, Zhangheng Road, Pudong New Area, Shanghai

Construction area: 4000㎡

Service content: laboratory planning and design, laboratory construction and construction, LAB+OFFICE

Laboratory construction is a complex system engineering. From construction to operation, power supply, water supply, gas supply, ventilation, temperature, humidity, safety measures, environmental protection and many other factors need to be considered comprehensively. Starting from the analysis of customer application needs, CEIDI provides the most suitable laboratory construction solutions based on budget, construction period, and enterprise needs, so that the constructed laboratory can not only meet the individual needs of the enterprise, but also meet the relevant laws and regulations , Industry rules, testing standards, safety standards and other mandatory planning requirements, and adapt to the increasing needs of future laboratories.

Technology is the driving force of CEIDI's growth, and service is the guarantee for CEIDI's sustainable development. For more construction details, the editor will follow up, so stay tuned!